0 Items
Select Page

Flavivirus Receptors

The Native Antigen Company manufacturers highly purified virus-host cell receptors using state-of-the-art expression and purification techniques. On request we can also undertake custom preparation of recombinant and native proteins for a broad range of disease states.

Flavivirus Receptors Background

Viruses are obligate intracellular pathogens and consequently need to gain entry into a host cell for completion of their life cycle. In order to enter to a cell, viruses attach to specific receptor molecules on the cell surface; molecules which also play an important role in normal cell function. Different viruses have evolved complex mechanisms to bind to these membrane-associated proteins and gain access to the cell interior.

Flaviviridae are small enveloped positive strand RNA viruses of an approximate diameter of 50 nm, which replicate in the cytoplasm of their respective host cell. The flavivirus family includes many mosquito-borne viruses, including Dengue virus (DENV), Yellow fever virus (YFV), West-Nile virus (WNV), Japanese encephalitis virus (JEV), Zika virus (ZIKV) and tick-borne encephalitis virus (TBEV), as well as blood-borne hepatitis C virus (HCV) (Knipe & Howley, 2013).

Flaviviruses enter cells by interaction of their E glycoprotein with cell surface receptors; these allow the virions to absorb onto the cell surface and enter the cells through receptor-mediated endocytosis. Secondary receptors may also be utilised to puncture the membrane or for fusion with the host cell. A specific receptor for internalization of flaviviruses into host cells has not yet been identified. It is believed that flaviviruses make initial contact with the host cell by binding to glycosaminoglycans (GAGs), such as heparan-sulfate proteoglycans or syndecans. However, the identity of the cellular receptors that mediate flavivirus entry and infection is still poorly known. A large number of attachment molecules such as DC-SIGN have been described as flavivirus candidate receptors in different cell types, but their precise role in virus endocytosis remains obscure. The best-characterized candidate proteins to date are C-type lectin receptors (CLEC5A) and the phosphatidylserine receptors, T-cell immunoglobulin and mucin domain (TIM) and TYRO3, AXL and MER (TAM) (Perera-Lecoin, et al., 2014; Laureti, et al., 2018).

Therefore, the E protein and its putative receptor and attachment molecules make promising targets for the design of antivirals and vaccine development.

References

Flavivirus Receptors

We offer a range of flavivirus receptors comprising highly purified recombinant proteins known to bind to a broad spectrum of viruses.

 

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Novel Coronavirus Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and vaccines.These antigens have been...

The Why and How of Protein Conjugation

In this blog, Lead Assay Development Scientist, Toni Ertl discusses the basics of protein conjugation and introduces our new range of conjugation kits for the labelling of antigens and antibodies.Detecting Proteins If you’re trying to detect or measure the presence...

Going Viral: Why We Need New Diagnostics For a Safe and Effective Dengue Vaccine

This article is taken from European Biopharmaceutical Review January 2020, pages 44-46. © Samedan Ltd.The Dengue VirusDengue is the world’s most prevalent and consequential arboviral disease. Current estimates indicate that as many as 390 million dengue infections...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

4 + 12 =

Live Customer Feedback

Join our mailing list

* indicates required